Literature DB >> 12038916

Discussion sections in reports of controlled trials published in general medical journals.

Mike Clarke1, Phil Alderson, Iain Chalmers.   

Abstract

CONTEXT: Reliable interpretation of the results of a controlled trial entails setting its results in the context of similar research. A previous study showed that most reports of controlled trials published in 5 general medical journals in May 1997 were deficient in this respect. We assessed the extent to which reports of controlled trials published in the same 5 journals discussed new results in light of the totality of evidence from other controlled trials.
METHODS: Assessment of the discussion sections in all 33 reports of randomized trials published during May 2001 in Annals of Internal Medicine, BMJ, JAMA, The Lancet, and The New England Journal of Medicine.
RESULTS: Three reports appeared to have been the first published trials to address the questions studied. In none of the remaining 30 reports were the results of the new trial discussed in the context of an updated systematic review of other trials. Although reference was made to relevant systematic reviews in 3 of these 30 reports, there was no integration, quantitative or qualitative, of the results of the new trials in an update of these reviews. In the remaining 27 reports, there was no evidence that any systematic attempt had been made to set the new results in the context of previous trials.
CONCLUSIONS: Between 1997 and 2001, there was no evidence of progress in the proportion of reports of trials published in general medical journals that discussed the new results within the context of, or with reference to, up-to-date systematic reviews of relevant evidence from other controlled trials.

Entities:  

Mesh:

Year:  2002        PMID: 12038916     DOI: 10.1001/jama.287.21.2799

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  17 in total

Review 1.  Users' guide to detecting misleading claims in clinical research reports.

Authors:  Victor M Montori; Roman Jaeschke; Holger J Schünemann; Mohit Bhandari; Jan L Brozek; P J Devereaux; Gordon H Guyatt
Journal:  BMJ       Date:  2004-11-06

2.  Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report.

Authors:  Mike Clarke; Sally Hopewell; Iain Chalmers
Journal:  J R Soc Med       Date:  2007-04       Impact factor: 5.344

3.  Why promote the findings of single research studies?

Authors:  Paul Wilson; Mark Petticrew; Mike Calnan; Irwin Nazareth
Journal:  BMJ       Date:  2008-03-29

4.  Significance testing as perverse probabilistic reasoning.

Authors:  M Brandon Westover; Kenneth D Westover; Matt T Bianchi
Journal:  BMC Med       Date:  2011-02-28       Impact factor: 8.775

5.  The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses.

Authors:  John P A Ioannidis
Journal:  Milbank Q       Date:  2016-09       Impact factor: 4.911

6.  Methodology and analytic techniques used in clinical research: associations with journal impact factor.

Authors:  Lindsay M Kuroki; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Obstet Gynecol       Date:  2009-10       Impact factor: 7.661

7.  Determining the reporting quality of RCTs in clinical pharmacology.

Authors:  Edward Mills; Yoon K Loke; Ping Wu; Victor M Montori; Daniel Perri; David Moher; Gordon Guyatt
Journal:  Br J Clin Pharmacol       Date:  2004-07       Impact factor: 4.335

8.  The James Lind Initiative.

Authors:  Iain Chalmers
Journal:  J R Soc Med       Date:  2003-12       Impact factor: 18.000

Review 9.  The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy.

Authors:  Peter O Behan; Abhijit Chaudhuri
Journal:  Inflammopharmacology       Date:  2010-09-24       Impact factor: 5.093

10.  Are decision trees a feasible knowledge representation to guide extraction of critical information from randomized controlled trial reports?

Authors:  Grace Y Chung; Enrico Coiera
Journal:  BMC Med Inform Decis Mak       Date:  2008-10-28       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.